PositiveID Also Provides Update on Its Firefly Product and Its Relationships With Large Government Contractors
AUSTIN, Texas, April 7, 2014 (GLOBE NEWSWIRE) — SmallCapVoice.com, Inc. announced today that a new audio interview with PositiveID Corporation (“PositiveID” or the “Company”) (OTCQB:PSID), a developer of biological detection and diagnostics solutions, is now available. The interview can be heard at http://smallcapvoice.com/blog/4-3-14-smallcapvoice-interview-with-positiveid-corporation-psid
PositiveID’s Chairman and Chief Executive Officer, William J. Caragol, called into SmallCapVoice.com to discuss the Company’s recently announced contract for its M-BAND system to support a Department of Defense program. Also included in the interview are Mr. Caragol’s insights into the Company’s catalysts for the remainder of 2014, an update on PositiveID’s other exciting offering the Firefly product, and a discussion of the Company’s relationships with large government contractors.
SmallCapVoice.com is a recognized corporate investor relations firm, with clients nationwide, known for its ability to help emerging growth companies build a following among retail and institutional investors. SmallCapVoice.com utilizes its stock newsletter to feature its daily stock picks, audio interviews, as well as its clients’ financial news releases. SmallCapVoice.com also offers individual investors all the tools they need to make informed decisions about the stocks they are interested in. Tools like stock charts, stock alerts, and Company Information Sheets can assist with investing in stocks that are traded on the OTC BB and Pink Sheets. To learn more about SmallCapVoice.com and their services, please visit http://www.smallcapvoice.com/services.html.
About PositiveID Corporation
PositiveID Corporation is an emerging growth company and developer of biological detection systems for America’s homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment. For more information on PositiveID, please visit http://www.PositiveIDCorp.com.
Statements about PositiveID’s future expectations made in its interview with SmallCapVoice.com, including, without limitation, statements made on its opportunities for its M-BAND and Firefly technologies, constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and PositiveID’s actual results could differ materially from expected results. Additional information about these and other factors that could affect the Company’s business is set forth in the Company’s various filings with the Securities and Exchange Commission, including those set forth in the Company’s 10-K filed on April 16, 2013, and 10-Qs filed on May 20, 2013, August 14, 2013, as amended on August 19, 2013, and November 19, 2013, under the caption “Risk Factors.” The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.
Stuart T. Smith